 "reddy, dr reddy's")
With the decline in revenues from the US market, Dr Reddy's Laboratories (DRL) is currently focusing on improving its geographical diversification in Europe and emerging markets. It is planning to enter new markets through partnerships and acquisitions, according to company's co-chairman and CEO G V Prasad.
The Hyderabad-based company has expanded in China by setting up its office. It is in the process of filing several oncology products, which will boost its revenues in this country over the next 3-5 years. It has also opened offices in many other emerging markets.
"We are planning to scale up our business across Europe
